1.
Kwatra SG, de Bruin-Weller M, Silverberg JI, Lio P, Deleuran M, Aydin H, Calimlim BM, Lane MC, Liu Y, Ofori S, Weidinger S. Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib. Acta Derm Venereol [Internet]. 2024 May 6 [cited 2024 Jul. 14];104:adv18452. Available from: https://medicaljournalssweden.se/actadv/article/view/18452